The School of Pharmacy welcomes the incoming Class of 2017; they are among the most qualified of our incoming students. We are fortunate that we are able to recruit a diverse and highly qualified student body. This year, the school is moving forward on a variety of initiatives. As part of the university’s $1.7 B in funding for Next Generation CT we are preparing a strategic vision for the school that will integrate our goals with those of the university. We anticipate an expansion of our basic science activities through the Department of Pharmaceutical Sciences and our clinical activities through the Department of Pharmacy Practice. We have hired two new faculty in outcomes research and are currently searching for two new faculty in basic science, one in pharmacogenetics and the other in medicinal chemistry. As Next Generation CT initiatives unfold, we anticipate several new faculty positions opening within the school over the next few years. The school continues its efforts to enhance human health through our scholarly activities. Diane Burgess recently received $1 M in grants from the FDA to investigate novel drug delivery forms. Thomas Buckley recently received a $500K grant from the Connecticut Department of Public Health to enhance the role of pharmacist in efforts to prevent and control disease. This grant was in collaboration with Angelo DeFazio of Arrow Pharmacies and highlights our efforts to work collaboratively with the community to enhance the profession. Together these grants highlight our vision of bridging drug discovery to development to optimal clinical practice. Finally, I will note that our national search for a new dean is moving forward on schedule. We anticipate completion of the search and naming the new dean in early 2014.
John B. Morris, Ph.D.